Pharmaceutical composition containing 4-oxo-butynic acids
US6143787A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1999 |
| Grant date | Nov 7, 2000 |
| Priority date | — |
| Expiry date | Feb 2, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition comprising, as active principle, a compound of formula: ##STR1## in which the groups A and B are chosen, independently of each other, from: a mono-, bi- or tricyclic aryl group having from 6 to 14 carbon atoms; PA2 a heteroaromatic group chosen from pyridyl, pyrimidyl, pyrrolyl, furyl and thienyl groups; PA2 an alkyl group having from 1 to 14 carbon atoms; PA2 a cycloalkyl group having from 5 to 8 carbon atoms; PA2 a saturated heterocyclic group chosen from tetrahydrofuryl, tetrahydropyranyl, piperidyl and pyrrolidinyl groups; to its solvate or to a salt of this acid with a pharmaceutically acceptable base. Figures: none.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.